Oxford Cardiomox Ltd(Cardiomox) focuses on developing and manufacturing the new generation of magnetocardiography (MCG) medical device for non-invasive heart diseases diagnosis.


Non-invasive, non-contact properties, high sensitivity, simplicity in carrying out examinations and total security for patients make this technique really instrumental not only for researchers involved in studying heart’s electrophysiology but for cardiology practitioners as well.

  • MCG is a completely noninvasive method that permits the registration of cardiac electrical activity at multiple sites in a plane above the chest cage without the need for electrodes.
  • MCG measures the magnetic fields emitted by the human heart from small currents by electrically active cells of the heart muscle.
  • MCG is both a method to record cardiac signals and to provide 3D functional imaging of cardiac electrophysiology.